
The Rise Fund
Description
The Rise Fund is a leading global impact investing fund managed by TPG, a prominent private equity firm. Launched in 2016, the fund is dedicated to achieving measurable social and environmental impact alongside competitive financial returns. It operates on the belief that large-scale global problems can be solved with market-based solutions, and it employs a proprietary 'Impact Multiple of Money' (IMM) methodology to quantify and manage the impact generated by its portfolio companies.
The fund's investment strategy focuses on growth-stage companies across seven core sectors: Education, Energy, Food & Agriculture, Financial Services, Healthcare, Technology, Media & Telecom (TMT), and Real Estate. The Rise Fund seeks out businesses that are already established and demonstrate a proven ability to generate positive impact, providing them with capital and strategic support to scale their operations and amplify their societal contributions. This approach emphasizes deep engagement with portfolio companies to drive both financial performance and impact outcomes.
The Rise Fund has successfully raised significant capital, underscoring its prominence in the impact investing landscape. The Rise Fund I closed with over $2 billion in commitments in 2017, demonstrating strong investor confidence in its dual mandate. Building on this success, The Rise Fund II closed in 2021 with $2.6 billion, further expanding its capacity to invest in impactful enterprises globally. Typically, the fund targets equity investments ranging from $50 million to $250 million per company, reflecting its focus on substantial growth equity rounds.
Investor Profile
The Rise Fund has backed more than 64 startups, with 2 new investments in the last 12 months alone. The firm has led 41 rounds, about 64% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, India, Canada.
- Strong thematic focus on Health Care, Biotechnology, Financial Services.
- Led 2 rounds in the past year.
- Typical check size: $50M – $250M.
Stage Focus
- Series C (19%)
- Series B (19%)
- Series Unknown (17%)
- Series A (13%)
- Series D (11%)
- Private Equity (8%)
- Series E (5%)
- Seed (5%)
- Series F (3%)
- Post Ipo Equity (2%)
Country Focus
- United States (67%)
- India (9%)
- Canada (3%)
- Israel (3%)
- Argentina (3%)
- China (3%)
- Kenya (2%)
- Hong Kong (2%)
- United Kingdom (2%)
- Botswana (2%)
Industry Focus
- Health Care
- Biotechnology
- Financial Services
- Therapeutics
- Software
- Medical
- Fintech
- Solar
- Education
- Renewable Energy
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.